Retina Consultants of Delmarva
Easton, Maryland, 21601, United States
NCT Number: NCT07779356
Prospective comparative clinical study.
One hundred eyes of 50 patients were included. All patients received bilateral same-day intravitreal injections, with Iheezo administered to only one randomly selected eye and standard topical anesthesia administered to the contralateral control eye. Ocular discomfort was assessed using a 0-10 numeric rating scale at 2 minutes, 1 hour, 6-12 hours, and 24 hours following injection. The primary longitudinal analysis used a linear mixed-effects model incorporating treatment group, assessment time, and treatment-by-time interaction as fixed effects and patient as a random effect. Between-group differences at individual time points were evaluated using Welch two-sample comparisons with Holm adjustment for multiple comparisons. Patient-level mean discomfort across the four assessments was also compared between groups.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Easton, Maryland, 21601, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Iheezo applied prior to injection
Standard anesthesia in practice, as proparacaine drops plus lidocaine pledget
Time frame: 2 minutes to 24 hours after injection
Rated 0-10 in each eye
Retina Consultants of Delmarva
Other
Comparative Evaluation of Patient Comfort Following Intravitreal Injections Using Iheezo Versus Standard Anesthesia in a Private Retina Practice
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02390245
Arterial Occlusive Diseases, Branch Retinal Arterial Occlusion
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT00101764
Cardiovascular Diseases, Choroid Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT04008121
Cardiovascular Diseases, Diabetes Complications
Ann Arbor, Michigan, United States
View Trial DetailsNCT04141891
Acute Coronary Syndrome, Aortic Stenosis, Subvalvular
La Jolla, California, United States
View Trial Details